TOCQUEVILLE ASSET MANAGEMENT L.P. - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$463,000
+353.9%
57,500
+283.3%
0.01%
+500.0%
Q4 2013$102,000
-83.8%
15,000
-56.3%
0.00%
-87.5%
Q3 2013$631,000
+11.7%
34,300
+6.2%
0.01%0.0%
Q2 2013$565,00032,3000.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders